Publication | Closed Access
Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
357
Citations
25
References
2014
Year
InflammationAllergyImmunologyHyperlipidemiaVascular BiologyLipoprotein MetabolismImmunotherapyMedicineAtherosclerosisDyslipidemiaAmg 145
| Year | Citations | |
|---|---|---|
Page 1
Page 1